GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gennex Laboratories Ltd (BOM:531739) » Definitions » Total Long-Term Liabilities

Gennex Laboratories (BOM:531739) Total Long-Term Liabilities : ₹169 Mil (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Gennex Laboratories Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Gennex Laboratories's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ₹169 Mil.

Gennex Laboratories Total Long-Term Liabilities Historical Data

The historical data trend for Gennex Laboratories's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gennex Laboratories Total Long-Term Liabilities Chart

Gennex Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.69 0.03 162.88 132.16 168.93

Gennex Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.16 - 161.34 - 168.93

Gennex Laboratories Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Gennex Laboratories Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Gennex Laboratories's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Gennex Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gennex Laboratories Ltd (BOM:531739) » Definitions » Total Long-Term Liabilities
Comparable Companies
BOM:500009 NSE:BALAXI BOM:524506 BOM:531569 BOM:524636 BOM:539730 BOM:524572 BOM:532878 BOM:532039 BOM:524654 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Akash Ganga, Plot No. 144, 4th Floor, Srinagar Colony, Hyderabad, TG, IND, 500 073
Website
https://www.gennexlab.com
Gennex Laboratories Ltd is engaged in the manufacturing of bulk drugs, and intermediates, Biotech Products. Geographically, the group has a business presence in Bangladesh, Egypt, Germany, Guatemala, Iran, Israel and other countries. Its products include Guaifenesin, Methocarbamol, Fluconazole and Phenazopyridine, among others.

Gennex Laboratories Headlines

No Headlines